Literature DB >> 11353884

[Prevalence of type 2 diabetes mellitus and glucose intolerance in the Setif area (Algeria)].

R Malek1, F Belateche, S Laouamri, M Hamdi-Cherif, A Touabti, W Bendib, A Nechadi, F Z Mekideche, S Hanat.   

Abstract

OBJECTIVE: Diabetes mellitus stands as a major public health issue in Algeria and has an important socioeconomical impact. Our study involved a representative sample of 1457 subjects and aimed at assessing the prevalence of type 2 diabetes and glucose intolerance in the population of Setif Wilaya, aged between 30 and 64 years old.
MATERIAL AND METHODS: Diagnosis was based on oral glucose tolerance test, according to World Health Organisation criteria.
RESULTS: Diabetes prevalence was 8.2% (CI: 95%: 6.8% to 9.6%). It increased with age, while 50% of cases were undiagnosed, without any difference according to sex nor urban (7.3%)/rural (9.7%) distribution. Glucose intolerance prevalence was 7.1 (CI 95%: 5,8% to 8,4%). Age-standardized prevalence, according to world population data provided by WHO, was 9.08% for diabetes and 7.5% for glucose intolerance. When the new American Diabetes Association Criteria were used, prevalence of type 2 diabetes was 8.8 (CI: 95%: 7.3% to 10.2%) and that of fasting hyperglycemia was 6.9% (CI: 95%: 5.6 to 8.2). According to these new criteria, among the 66 cases with undiagnosed diabetes, 79% presented with a fasting blood glucose > or =126 mg/dl.
CONCLUSION: This relatively high diabetes prevalence calls for an appropriate management and health education, particularly focused on high risk subjects. These results bring the the first detailed prevalence data in an Algerian population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353884

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  8 in total

1.  First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.

Authors:  Olfa Bahri; Sayeh Ezzikouri; Nissaf Ben Alaya-Bouafif; Fella Iguer; Abdallah Essaid El Feydi; Hafedh Mestiri; Moustapha Benazzouz; Tahar Khalfallah; Rajaa Afifi; Latifa Elkihal; Salah Berkane; Agnes Marchio; Nabil Debzi; Anne Dejean; Pascal Pineau; Hinda Triki; Soumaya Benjelloun
Journal:  World J Hepatol       Date:  2011-01-27

Review 2.  Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis.

Authors:  Yu Tong; Ying Lin; Yuan Zhang; Jiyun Yang; Yawei Zhang; Hengchuan Liu; Ben Zhang
Journal:  BMC Med Genet       Date:  2009-02-19       Impact factor: 2.103

3.  Diabetes mellitus and Ramadan in Algeria.

Authors:  Farida Chentli; Said Azzoug; Mohammed El Amine Amani; Aldjia Elgradechi
Journal:  Indian J Endocrinol Metab       Date:  2013-10

Review 4.  Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications.

Authors:  Larbi Lamri; Erofile Gripiotis; Alessandra Ferrario
Journal:  Global Health       Date:  2014-02-24       Impact factor: 4.185

5.  Gender discrimination for women with diabetes mellitus in Algeria.

Authors:  Farida Chentli; Said Azzoug; Djamila Meskine; Aldjia El Gradechi
Journal:  Indian J Endocrinol Metab       Date:  2014-11

Review 6.  A systematic analysis on prevalence and sub-regional distribution of undiagnosed diabetes mellitus among adults in African countries.

Authors:  Getenet Dessie; Henok Mulugeta; Desalegne Amare; Ayenew Negesse; Fasil Wagnew; Temsgen Getaneh; Akililu Endalamew; Yibeltal Wubale Adamu; Gizachew Tadesse; Aster Workineh; Sarah Lebu
Journal:  J Diabetes Metab Disord       Date:  2020-09-22

Review 7.  Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review.

Authors:  Manouk Bos; Charles Agyemang
Journal:  BMC Public Health       Date:  2013-04-25       Impact factor: 3.295

8.  Prevalence of diabetes in Northern African countries: the case of Tunisia.

Authors:  Habiba Ben Romdhane; Samir Ben Ali; Wafa Aissi; Pierre Traissac; Hajer Aounallah-Skhiri; Souha Bougatef; Bernard Maire; Francis Delpeuch; Noureddine Achour
Journal:  BMC Public Health       Date:  2014-01-28       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.